How long does someone live with DLBCL? We tend to think of DLBCL patients as I said, close to 60 to 65% of people are going to be survivors and no longer patients. So the treatment usually entails a short course of treatment for anywhere from, you know, five to six months or lesser. That's what we are trying to improve our treatment approaches. But after that, then you are potentially cured of your disease and then they become survivors and we don't consider them any longer as patients. Sometimes their survival might be shortened due to the complications from these therapies. But again, 60 to 70% of the patients are not going to die from the diffuse large B cell lymphoma itself. It could be cardiac complications, for example. Due to some of the chemotherapy as we administer from the get go, some of the patients, and this is a small percentage, three to five percent at most, can have heart failure later in life and they might die complications from heart failure, for example. More often than not, cardiac complications or infections could be an issue while they are going through treatment or right after the treatment is completed because these patients' immune system is going to compromise a hit during treatment and right after the treatment as well for a while. So infections are one of the biggest complications. Rarely patients might run into issues like bleeding or very rarely kidney or renal problems. You know, like 65, 70% of the patients are completely cured of the disease so they can have a normal life after that so it's a very high rate of response. Other require more treatment so you have to keep treating the patients longer.